Vimarsana
Biggest News Aggregation in the World

Page 4 - Life Edit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Edit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Edit Today - Breaking & Trending Today

ElevateBio Raises $401M in Series D Financing - Vimarsana News

ElevateBio Raises $401M in Series D Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Novo Nordisk strikes gene editing deal with Durham-based Life Edit - Vimarsana News

Novo Nordisk strikes gene editing deal with Durham-based Life Edit

Gene editing from a Durham-based firm that will target possible new therapeutics has led to a deal with international drug firm Novo Nordisk worth a potential $2 billion if not more. Here are the details.

Moderna, Inc. (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript - Vimarsana News

Moderna, Inc. (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to Moderna's First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.

ModernaTX, Inc: Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates - Vimarsana News

ModernaTX, Inc: Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates

First quarter 2023 revenues of $1.9 billion; GAAP net income of $79 million and GAAP diluted EPS of $0.19Company in negotiations for new orders for fall of 2023 in U.S., Japan, and EU, in addition to reiterating

Moderna (MRNA) Q1 2023 Earnings Call Transcript - Vimarsana News

Moderna (MRNA) Q1 2023 Earnings Call Transcript

MRNA earnings call for the period ending March 31, 2023.

Source: fool.com